Work

Abstract 6037: Copper-67 as a next-generation radioconjugate warhead for cancer therapy

Year: 2024

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2024-6037

Authors: Matt Harris, Kurt Gehlsen, Lachlan McInnes, Jason Lewis

Institutions: Clarity Pharmaceuticals Ltd. (Australia), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4393095666

Cites:

Cited by:

Related to: 10